ne
sh
ne
la
tz
sh
Sp
ne
la
sh
Sp
ne
la
tz
NR 508 Week 4 Midterm Exam
sh
Sp
ne
NR 508: ADVANCED PHARMACOLOGY
la
sh
(Complete solutions and resources for the course exam)
Sp
ne
la
tz
sh
Sp
ne
la
sh
Sp
ne
la
tz
sh
Sp
ne
la
sh
Sp
ne
a
tz
l
sh
Sp
ne
la
sh
Sp
la
Sp
, ne
sh
ne
NR 508 Week 4 Midterm Exam
la
tz
sh
Sp
ne
1. A patient asks a primary care NP whether over-the-counter drugs are safer than
prescription drugs. The NP should explain that over-the-counter drugs are: (Points : 2)
la
generally safe when label information is understood and followed.
sh
Sp
safer because over-the-counter doses are lower than prescription doses of the same
drug.
ne
less safe because they are not well regulated by the Food and Drug Administration
la
(FDA).
tz
sh
not extensively tested, so claims made by manufacturers cannot be substantiated.
Sp
ne
la
Question 2.2. A woman who is being treated with radiotherapy for breast cancer asks her
sh
primary care nurse practitioner (NP) about using dietary supplements to improve her chance
Sp
of recovery. The NP should tell her that: (Points : 2)
ne
vitamin E is not harmful but has not been shown to change outcomes.
la
no supplements have been shown to alter outcomes or response to therapy.
tz
sh
folic acid and other B vitamins may improve ability to tolerate chemotherapy.
Sp
ne
vitamin C, taken at least 6 days per week, may lower her risk of cancer recurrence.
la
sh
Sp
Question 3.3. A patient with type 2 diabetes mellitus takes metformin (Glucophage) 1000 mg
ne
twice daily and glyburide (Micronase) 12 mg daily. At an annual physical examination, the BMI
is 29 and hemoglobin A1c is 7.3%. The NP should: (Points : 2)
la
begin insulin therapy.
tz
change to therapy with colesevelam (Welchol).
sh
Sp
ne
add a third oral antidiabetic agent to this patient’s drug regimen.
la
enroll the patient in a weight loss program to achieve better glycemic control.
sh
Sp
Question 4.4. A patient comes to the clinic to discuss weight loss. The primary care NP notes
ne
a BMI of 32 and performs a health risk assessment that reveals no obesity-related risk factors.
The NP should recommend: (Points : 2)
a
tz
orlistat (Xenical).
l
sh
surgical intervention.
Sp
ne
changes in diet and exercise.
la
changes in diet and exercise along with short-term phentermine.
sh
Sp
la
Sp
, ne
sh
ne
la
Question 5.5. Which of the following statements is true about the prescribing practices of
physicians? (Points : 2)
tz
sh
Older physicians tend to prescribe more appropriate medications than younger
Sp
physicians.
ne
Antibiotic medications remain in the top five classifications of medications prescribed.
la
Most physicians rely on a “therapeutic armamentarium” that consists of less than 100
drug preparations per physician.
sh
Sp
The dominant form of drug information used by primary care physicians continues to
ne
be that provided by pharmaceutical companies.
la
tz
Question 6.6. A primary care NP is aware that many patients in the community use herbal
sh
Sp
remedies to treat various conditions. The NP understands the importance of: (Points : 2)
ne
learning about the actions, uses, doses, and toxicities of these agents.
la
prescribing these agents when possible to ensure safe dosing.
counseling patients to stop using herbal products to avoid toxic side effects.
sh
Sp
teaching patients that these products are unregulated and unsafe to use.
ne
la
Question 7.7. A patient who is at risk for DVT tells the primary care NP she has just learned
tz
she is pregnant. The NP should expect that this patient will use which of the following
sh
Sp
anticoagulant medications? (Points : 2)
ne
Aspirin
la
Heparin
Dabigatran
sh
Sp
Warfarin
ne
la
Question 8.8. As primary care nurse practitioners (NPs) continue to develop their role as
tz
prescribers of medications, it will be important to: (Points : 2) sh
Sp
attain the same level of expertise as physicians who currently prescribe medications.
ne
learn from the experiences of physicians and develop expertise based on evidence-
la
based practice.
maintain collaborative and supervisorial relationships with physicians who will
sh
Sp
oversee prescribing practices.
ne
develop relationships with pharmaceutical representatives to learn about new
medications as they are developed.
a
tz
l
sh
Sp
Question 9.9. A patient with a previous history of myocardial infarction (MI) who takes
ne
nitroglycerin for angina develops hypertension. The primary care NP is considering ordering
an ACE inhibitor. Preliminary laboratory tests reveal decreased renal function. The NP should:
(Points : 2)
la
sh
Sp
la
Sp
sh
ne
la
tz
sh
Sp
ne
la
sh
Sp
ne
la
tz
NR 508 Week 4 Midterm Exam
sh
Sp
ne
NR 508: ADVANCED PHARMACOLOGY
la
sh
(Complete solutions and resources for the course exam)
Sp
ne
la
tz
sh
Sp
ne
la
sh
Sp
ne
la
tz
sh
Sp
ne
la
sh
Sp
ne
a
tz
l
sh
Sp
ne
la
sh
Sp
la
Sp
, ne
sh
ne
NR 508 Week 4 Midterm Exam
la
tz
sh
Sp
ne
1. A patient asks a primary care NP whether over-the-counter drugs are safer than
prescription drugs. The NP should explain that over-the-counter drugs are: (Points : 2)
la
generally safe when label information is understood and followed.
sh
Sp
safer because over-the-counter doses are lower than prescription doses of the same
drug.
ne
less safe because they are not well regulated by the Food and Drug Administration
la
(FDA).
tz
sh
not extensively tested, so claims made by manufacturers cannot be substantiated.
Sp
ne
la
Question 2.2. A woman who is being treated with radiotherapy for breast cancer asks her
sh
primary care nurse practitioner (NP) about using dietary supplements to improve her chance
Sp
of recovery. The NP should tell her that: (Points : 2)
ne
vitamin E is not harmful but has not been shown to change outcomes.
la
no supplements have been shown to alter outcomes or response to therapy.
tz
sh
folic acid and other B vitamins may improve ability to tolerate chemotherapy.
Sp
ne
vitamin C, taken at least 6 days per week, may lower her risk of cancer recurrence.
la
sh
Sp
Question 3.3. A patient with type 2 diabetes mellitus takes metformin (Glucophage) 1000 mg
ne
twice daily and glyburide (Micronase) 12 mg daily. At an annual physical examination, the BMI
is 29 and hemoglobin A1c is 7.3%. The NP should: (Points : 2)
la
begin insulin therapy.
tz
change to therapy with colesevelam (Welchol).
sh
Sp
ne
add a third oral antidiabetic agent to this patient’s drug regimen.
la
enroll the patient in a weight loss program to achieve better glycemic control.
sh
Sp
Question 4.4. A patient comes to the clinic to discuss weight loss. The primary care NP notes
ne
a BMI of 32 and performs a health risk assessment that reveals no obesity-related risk factors.
The NP should recommend: (Points : 2)
a
tz
orlistat (Xenical).
l
sh
surgical intervention.
Sp
ne
changes in diet and exercise.
la
changes in diet and exercise along with short-term phentermine.
sh
Sp
la
Sp
, ne
sh
ne
la
Question 5.5. Which of the following statements is true about the prescribing practices of
physicians? (Points : 2)
tz
sh
Older physicians tend to prescribe more appropriate medications than younger
Sp
physicians.
ne
Antibiotic medications remain in the top five classifications of medications prescribed.
la
Most physicians rely on a “therapeutic armamentarium” that consists of less than 100
drug preparations per physician.
sh
Sp
The dominant form of drug information used by primary care physicians continues to
ne
be that provided by pharmaceutical companies.
la
tz
Question 6.6. A primary care NP is aware that many patients in the community use herbal
sh
Sp
remedies to treat various conditions. The NP understands the importance of: (Points : 2)
ne
learning about the actions, uses, doses, and toxicities of these agents.
la
prescribing these agents when possible to ensure safe dosing.
counseling patients to stop using herbal products to avoid toxic side effects.
sh
Sp
teaching patients that these products are unregulated and unsafe to use.
ne
la
Question 7.7. A patient who is at risk for DVT tells the primary care NP she has just learned
tz
she is pregnant. The NP should expect that this patient will use which of the following
sh
Sp
anticoagulant medications? (Points : 2)
ne
Aspirin
la
Heparin
Dabigatran
sh
Sp
Warfarin
ne
la
Question 8.8. As primary care nurse practitioners (NPs) continue to develop their role as
tz
prescribers of medications, it will be important to: (Points : 2) sh
Sp
attain the same level of expertise as physicians who currently prescribe medications.
ne
learn from the experiences of physicians and develop expertise based on evidence-
la
based practice.
maintain collaborative and supervisorial relationships with physicians who will
sh
Sp
oversee prescribing practices.
ne
develop relationships with pharmaceutical representatives to learn about new
medications as they are developed.
a
tz
l
sh
Sp
Question 9.9. A patient with a previous history of myocardial infarction (MI) who takes
ne
nitroglycerin for angina develops hypertension. The primary care NP is considering ordering
an ACE inhibitor. Preliminary laboratory tests reveal decreased renal function. The NP should:
(Points : 2)
la
sh
Sp
la
Sp
